• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Hip replacement recall: Yet another Johnson & Johnson implant lawsuit

Hip replacement recall: Yet another Johnson & Johnson implant lawsuit

March 8, 2011 By MassDevice staff

Legal roundup

Another lawsuit was added to the avalanche of litigation that DePuy Orthopaedics Inc. is facing over one of its hip implants, after a Tennessee woman sued the company over an allegedly faulty hip implant.

Kathern Hensley was implanted with a DePuy ASR XL Acetabular hip replacement system, according to a statement from the law firms representing the plaintiff.

Hensley alleges that she has been in "constant pain" from her DePuy hip replacement, and accuses Depuy of being aware of the device’s tendency to fail and cause the discomfort she experienced, the firms said. The lawsuit, Hensley v. DePuy Orthopedics Inc., et al., was filed March 4 in state court in San Francisco.

The Johnson & Johnson (NYSE:JNJ) subsidiary has fielded numerous lawsuits about its ASR metal-on-metal hip replacement since a complaint was filed by Florida resident Kathleen Margenau in June 2010 on the device. Margenau also alleges that the company was aware of the device’s problems when it was still selling and marketing it.

The Warsaw, Ind.-based company in August 2010 pulled the ASR XL Acetabular and ASR Hip Resurfacing systems from the market "due to the number of patients who required a second hip replacement procedure, called a revision surgery," according to a prepared statement from the company.

Here’s a roundup of recent legal actions associated with the medical device industry.

  • Steris to pay $20 million over sterilization system suit
    The U.S. District Court for Northern Ohio last week granted preliminary approval to a proposed settlement reached in a class action lawsuit filed by Chimicles & Tikellis LLP against Steris Corp. (NYSE:STE). The lawsuit is related to Steris’ marketing and sale of the Steris System 1 Sterile Processor (the SS1), a tabletop liquid chemical system that provides rapid, low-temperature processing of surgical instruments such as endoscopes and bronchoscopes. The Food & Drug Administration cleared the SS1 in 1988. The lawsuit filed by C&T alleges that Steris made several material changes to the SS1 Device after 1988 without obtaining the necessary clearance from the FDA, and that as a result, the FDA informed healthcare providers that use of the SS1 Device "should be discontinued as soon as practicable," but no later than August 2. Steris subsequently entered into a consent decree with the FDA to implement a transition plan whereby healthcare providers could return their SS1 Devices to Steris in exchange for a rebate. There are no allegations in this case that the SS1 Devices create a safety hazard, nor that anyone has been harmed as a result of using the SS1 Devices. Based on the number of eligible SS1 Devices and settlement options made available to each, C&T estimates that the settlement provides approximately $20 million of benefits to the class.
    Read more
  • Ex-Cyberonics CEO battles backdated options reports
    Robert Cummins, who stepped down as Cyberonics Inc. (NSDQ:CYBE) CEO in Nov. 2006 after allegations surfaced that he was the beneficiary of backdated stock options, is back in court claiming that he was defamed by reports from Suntrust Capital Markets Inc. analysts who mischaracterized options he had been granted as improperly backdated. Last December, Cummins and Cyberonics reported that he received a letter from the Securities and Exchange Commission that exonerated him. The letter stated that the SEC had completed its investigation of Cyberonics’s stock option practices commenced on June 9, 2006 and that it does not intend to recommend any enforcement action against Cummins, according to the company.
    Read more
  • Swedish court says Occlutech implants don’t violate St. Jude patent
    Occlutech GmbH received a favourable court ruling from Stockholm in the on-going patent litigation with St Jude Medical Inc. (NYSE:STJ) and its recent acquisition, AGA Medical. In the ruling by Stockholms tingsratt , the district court of Stockholm, the court does not see any basis for AGA-St Jude’s claim that the Occlutech ASD and PFO occluders violate any patent brought forward in the litigation. The Stockholm court decision thus is similar to the first instance ruling in the United Kingdom that was confirmed by the appeal court in the U.K., the last one received mid 2010. The U.K. ruling is final as the country’s supreme court did not allow an appeal requested by AGA. The favourable Stockholm ruling is also similar to first instance as well as appeal court decisions in The Hague, the last one obtained in the end of 2010. The rulings in Sweden and The Netherlands are subject to appeal by AGA-St Jude Medical.
    Read more
  • Allergan attempts to have Texas court toss breast implant marking suit
    Allergan Inc. (NYSE:AGN) asked the U.S. District Court for Eastern Texas to toss plaintiff Kilts Resources LLC’s false marking suit on grounds that it was no longer valid due to a recent decision that the statute governing the matter — a provision of the Patent Act — is unconstitutional. In the a qui tam action, Kilts alleges that Allergan falsely marked unpatented "CUI Brand Tissue Expanders," also known as breast implants, with expired patent numbers with the purpose of deceiving the public, according to court documents.

Filed Under: Legal News, News Well Tagged With: Allergan, cyberonics, depuysynthes, Johnson and Johnson, Occlutech GmbH, Steris Corp.

In case you missed it

  • House committee investigates $70M federal contract for AutoMedx ventilators
  • Edwards Lifesciences misses on earnings in Q4
  • COVID-19 assays sales power Hologic to Street-beating Q1
  • Stryker beats the Street on earnings but misses on revenue in Q4
  • How CGMs can inspire lifestyle changes
  • Johnson & Johnson gearing up for COVID-19 vaccine data announcement
  • Sanofi to provide COVID-19 vaccine manufacturing for rival Pfizer
  • Adapting to Pharma’s Next Normal – 2021 Pharmaceutical Trends
  • COVID-19 test sales boost Abbott in Street-beating Q4
  • Varian posts mixed bag Q1 results, expects Siemens Healthineers takeover to complete in early 2021
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
  • Titan Medical closes on $11.5M offering
  • GE ticks up on mixed-bag Q4
  • BD CEO Polen to also serve as board chair
  • Moderna details ‘proactive’ strategy to fight emerging COVID-19 variants  
  • Surmodics’ DCB shown non-inferior to Medtronic’s In.Pact Admiral
  • Longeviti Neuro Solutions ClearFit implant wins FDA clearance for use in ultrasound

RSS From Medical Design & Outsourcing

  • House committee investigates $70M federal contract for AutoMedx ventilators
    A Congressional committee has launched an investigation into a $70 million White House contract for ventilators that reportedly are inadequate to treat people with COVID-19. The Department of Defense signed a $16.2 million contract in spring 2020 to buy SAVe II ventilators, manufactured by AutoMedx (Addison, Tex.), from the supplier Combat Medical Systems, according to… […]
  • How CGMs can inspire lifestyle changes
    As an early adopter of fitness trackers such as the Fitbit, I’ve long appreciated the power of health data. But my recent experience with a continuous glucose monitor (CGM) has done far more to inspire me to look after my health — even as a nondiabetic. I had heard about the potential of such technology… […]
  • COVID-19 mask factory opens in N.J.
    Hudson Holdings Group today announced it has opened a factory to make up to tens of millions of protective masks a month. The Piscataway, N.J., site will produce more than 200 jobs, according to the company, which is in partnership on the project with the State of New Jersey. “Our ultimate goal is to help,”… […]
  • TE Connectivity posts Street-beating Q1 results, medical sales dip 12%
    TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus on Wall Street. The Schaffhausen, Switzerland-based company reported profits of $381 million, or $1.13 per share, on sales of $3.5 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 1365.4% sales growth of 11.2% compared with Q1 2020. Adjusted to… […]
  • Could this 3-D printed ‘biomesh’ minimize hernia repair complications?
    Some hernia mesh implants have been associated with adverse post-surgical complications. So researchers at Baylor College of Medicine have developed a 3D-printed biomesh to support and reinforce the damaged abdominal wall and facilitate the healing process. Mesh implants may fail because they promote the adhesion of the intestine, liver or other visceral organs to the… […]
  • Superior Sensor Technology launches versatile differential pressure sensors
    Superior Sensor Technology (Santa Clara, Calif.) today announced the launch of differential pressure sensors for industrial applications that support up to seven selectable pressure ranges in one device. Designed for a wide range of applications, the new ND Series sensors support pressure ranges as low as 62.5 Pa/0.25” H2O to as high as 345 mBar/5… […]
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
    Becton Dickinson (BD) is touting the results of a small, in-house study of its Veritor Plus antigen test over molecular (PCR) tests to indicate whether an infected person is more likely able to spread SARS-CoV-2. The peer-reviewed study compared antigen and PCR test results to positive results using a viral cell culture test. Viral growth… […]
  • TDK adds pressure sensors for ventilators
    TDK Corporation announced the launch of a new range of differential pressure sensors designed as printed circuit boards for use in medical devices. The sensors are designed for measurement ranges of 16 mbar full-scale (FS), 100 mbar FS and 7 bar FS, with accuracy of up to ±1% FS at temperatures from -20 °C to… […]
  • Pediatric device workshop scheduled for February
    A virtual public meeting on pediatric medical device development is scheduled for Feb. 9-11, 2021. Sponsors include the FDA, AdvaMed, the American Academy of Pediatrics and the Critical Path Institute, a public-private partnership that receives FDA funding. The System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop will focus on the… […]
  • Pedra wins breakthrough nod for perfusion system
    Singapore-based Pedra Technology announced today that the FDA has granted the company breakthrough device designation for the periprocedural use of its Xauron perfusion system in the treatment of critical limb-threatening ischemia (CLTI). CLTI is a severe form of peripheral artery disease (PAD) that is defined as ischemic rest pain, tissue loss or gangrene (tissue death) that… […]
  • Freudenberg Medical expands U.S. molding operations
    Freudenberg Medical announced that it has expanded injection molding operations at its Baldwin Park, Calif., operation, which is focused on thermoplastics. Freudenberg Medical Baldwin Park has added six injection molding machines including three new Arburg molding machines, a work cell for two-shot molding and a Wittmann Battenfeld micro-molding machine with in-process visual inspection capability. The… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS